Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry M Elliott

Showing results (261-270 of 292) with videos related to

Pageof 30
Sort By:
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[2023 ESC Guidelines for the management of cardiomyopathies]Elena Arbelo, Alexandros Protonotarios, Juan R Gimeno, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
JACC. Advances|January 29, 2025
Naxos Disease and Related Cardio-Cutaneous SyndromesAlexandros Protonotarios, Angeliki Asimaki, Cristina Basso, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 19, 2021
Correction to: The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Heart (British Cardiac Society)|May 27, 2020
Mutations in <i>TRIM63</i> cause an autosomal-recessive form of hypertrophic cardiomyopathyJoel Salazar-Mendiguchía, Juan Pablo Ochoa, Julian Palomino-Doza, et al.
JACC. Heart Failure|May 1, 2025
The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic CardiomyopathyJosé M Larrañaga-Moreira, Juan P Ochoa, Rosalía Peteiro-Debén, et al.
European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
Circulation|August 29, 2025
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect VariantsSoledad García Hernandez, Luis de la Higuera Romero, Adrián Fernández, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
Pageof 30

Showing results (261-270 of 292) with videos related to

Sort By:
Pageof 30
Giornale Italiano Di Cardiologia (2006)|October 30, 2023
[2023 ESC Guidelines for the management of cardiomyopathies]Elena Arbelo, Alexandros Protonotarios, Juan R Gimeno, et al.
Plos One|August 31, 2018
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathyEdgar T Hoorntje, Anna Posafalvi, Petros Syrris, et al.
JACC. Advances|January 29, 2025
Naxos Disease and Related Cardio-Cutaneous SyndromesAlexandros Protonotarios, Angeliki Asimaki, Cristina Basso, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|August 19, 2021
Correction to: The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 13, 2021
The genetic architecture of Plakophilin 2 cardiomyopathyAnnika M Dries, Anna Kirillova, Chloe M Reuter, et al.
Heart (British Cardiac Society)|May 27, 2020
Mutations in <i>TRIM63</i> cause an autosomal-recessive form of hypertrophic cardiomyopathyJoel Salazar-Mendiguchía, Juan Pablo Ochoa, Julian Palomino-Doza, et al.
JACC. Heart Failure|May 1, 2025
The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic CardiomyopathyJosé M Larrañaga-Moreira, Juan P Ochoa, Rosalía Peteiro-Debén, et al.
European Heart Journal|August 28, 2023
Emery-Dreifuss muscular dystrophy Type 1 is associated with a high risk of malignant ventricular arrhythmias and end-stage heart failureDouglas E Cannie, Petros Syrris, Alexandros Protonotarios, et al.
Circulation|August 29, 2025
Redefining the Genetic Architecture of Hypertrophic Cardiomyopathy: Role of Intermediate Effect VariantsSoledad García Hernandez, Luis de la Higuera Romero, Adrián Fernández, et al.
Circulation|December 2, 2017
International External Validation Study of the 2014 European Society of Cardiology Guidelines on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy (EVIDENCE-HCM)Constantinos O'Mahony, Fatima Jichi, Steve R Ommen, et al.
Pageof 30